Siga Technologies (SIGA) Non-Current Deferred Tax Liability (2010 - 2017)
Siga Technologies (SIGA) posted Non-Current Deferred Tax Liability of $306449.0 for Q3 2017, little changed on a QoQ basis from $307256.0 in Q2 2017, and up 8.71% year-over-year from $281889.0 in Q3 2016.
Siga Technologies (SIGA) Non-Current Deferred Tax Liability (2010 - 2017) Analysis & Trends
Siga Technologies' Non-Current Deferred Tax Liability history runs 5 years deep, the most recent figure standing at $306449.0 for Q3 2017.
- Quarterly Non-Current Deferred Tax Liability rose 8.71% year-over-year to $306449.0 in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $306449.0 (up 8.71% YoY) and the FY2016 annual result came in at $286066.0, up 7.69% from the prior year.
- Non-Current Deferred Tax Liability was $306449.0 for Q3 2017 at Siga Technologies, roughly flat from $307256.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $7.5 million in Q3 2015 and bottomed at $240973.0 in Q3 2014.
- A 4-year average of $1.8 million and a median of $286066.0 in 2016 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2015 — Non-Current Deferred Tax Liability surged 3020.62% — and 2016, when it slumped 96.25%.
- Siga Technologies' Non-Current Deferred Tax Liability stood at $244540.0 in 2014, then grew by 8.63% to $265643.0 in 2015, then advanced by 7.69% to $286066.0 in 2016, then gained by 7.13% to $306449.0 in 2017.
- Business Quant data shows SIGA's Non-Current Deferred Tax Liability at $306449.0 in Q3 2017, $307256.0 in Q2 2017, and $307256.0 in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 306,449.00 |
| Sep 30, 2017 | 306,449.00 |
| Jun 30, 2017 | 307,256.00 |
| Jun 30, 2017 | 307,256.00 |
| Mar 31, 2017 | 307,256.00 |
| Mar 31, 2017 | 307,256.00 |
| Dec 31, 2016 | 286,066.00 |
| Dec 31, 2016 | 286,066.00 |
| Sep 30, 2016 | 281,889.00 |
| Sep 30, 2016 | 281,889.00 |
| Jun 30, 2016 | 277,088.00 |
| Jun 30, 2016 | 277,088.00 |
| Mar 31, 2016 | 277,895.00 |
| Mar 31, 2016 | 277,895.00 |
| Dec 31, 2015 | 265,643.00 |
| Dec 31, 2015 | 265,643.00 |
| Sep 30, 2015 | 7.52 Mn |
| Sep 30, 2015 | 7.52 Mn |
| Jun 30, 2015 | 7.07 Mn |
| Jun 30, 2015 | 7.07 Mn |